Alejandro Garanto

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 36

Top Venues

Nucleic acid therapeutics

Cells

International journal of molecular sciences

Methods in molecular biology (Clifton, N.J.)

Radboudumc

Universitat de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Radboudumc Jan 01 2020

Netherlands

Junior Principal Investigator :: Human Genetics

Radboudumc Apr 01 2017

Netherlands

Assistant Professor :: Human Genetics

Radboudumc Oct 01 2012 - Mar 31 2017

Netherlands

Post-doc :: Human Genetics

Universitat de Barcelona Oct 03 2011 - Sep 15 2012

Spain

Post-doc :: Genetics

Universitat de Barcelona - Sep 30 2011

Spain

PhD candidate :: Genetics

Education History

Universitat de Barcelona - Oct 03 2011

Spain

PHD :: Genetics

Universitat de Barcelona

Spain

BSC

Publications

Nuria Suárez-Herrera, Alejandro Garanto, Rob W J Collin
Understanding and Rescuing the Splicing Defect Caused by the Frequent ABCA4 Variant c.4253+43G>A Underlying Stargardt Disease. Nucleic acid therapeutics 34 (2) (2024)
Nuria Suárez-Herrera, Catherina H Z Li, Nico Leijsten, Dyah W Karjosukarso, Zelia Corradi, Femke Bukkems, Lonneke Duijkers, Frans P M Cremers, Carel B Hoyng, Alejandro Garanto, Rob W J Collin
Preclinical Development of Antisense Oligonucleotides to Rescue Aberrant Splicing Caused by an Ultrarare ABCA4 Variant in a Child with Early-Onset Stargardt Disease. Cells 13 (7) (2024)
Nuria Suárez-Herrera, Catherina H Z Li, Nico Leijsten, Dyah W Karjosukarso, Zelia Corradi, Femke Bukkems, Lonneke Duijkers, Frans P M Cremers, Carel B Hoyng, Alejandro Garanto, Rob W J Collin
Preclinical Development of Antisense Oligonucleotides to Rescue Aberrant Splicing Caused by an Ultrarare ABCA4 Variant in a Child with Early-Onset Stargardt Disease. Cells 13 (7) (2024)
Nuria Suárez-Herrera, Alejandro Garanto, Rob W J Collin
Understanding and Rescuing the Splicing Defect Caused by the Frequent ABCA4 Variant c.4253+43G>A Underlying Stargardt Disease. Nucleic acid therapeutics 34 (2) (2024)
Nuria Suárez-Herrera, Alejandro Garanto, Rob W J Collin
Understanding and Rescuing the Splicing Defect Caused by the Frequent ABCA4 Variant c.4253+43G>A Underlying Stargardt Disease. Nucleic acid therapeutics (2024)
Nuria Suárez-Herrera, Catherina H Z Li, Nico Leijsten, Dyah W Karjosukarso, Zelia Corradi, Femke Bukkems, Lonneke Duijkers, Frans P M Cremers, Carel B Hoyng, Alejandro Garanto, Rob W J Collin
Preclinical Development of Antisense Oligonucleotides to Rescue Aberrant Splicing Caused by an Ultrarare ABCA4 Variant in a Child with Early-Onset Stargardt Disease. Cells 13 (7) (2024)
Zelia Corradi, Rebekkah J Hitti-Malin, Laura A de Rooij, Alejandro Garanto, Rob W J Collin, Frans P M Cremers
Antisense Oligonucleotide-Based Rescue of Complex Intronic Splicing Defects in ABCA4 . Nucleic acid therapeutics 34 (3) (2024)
Nuria Suárez-Herrera, Catherina H Z Li, Nico Leijsten, Dyah W Karjosukarso, Zelia Corradi, Femke Bukkems, Lonneke Duijkers, Frans P M Cremers, Carel B Hoyng, Alejandro Garanto, Rob W J Collin
Preclinical Development of Antisense Oligonucleotides to Rescue Aberrant Splicing Caused by an Ultrarare ABCA4 Variant in a Child with Early-Onset Stargardt Disease. Cells 13 (7) (2024)
Nuria Suárez-Herrera, Catherina H Z Li, Nico Leijsten, Dyah W Karjosukarso, Zelia Corradi, Femke Bukkems, Lonneke Duijkers, Frans P M Cremers, Carel B Hoyng, Alejandro Garanto, Rob W J Collin
Preclinical Development of Antisense Oligonucleotides to Rescue Aberrant Splicing Caused by an Ultrarare ABCA4 Variant in a Child with Early-Onset Stargardt Disease. Cells 13 (7) (2024)
Zelia Corradi, Rebekkah J Hitti-Malin, Laura A de Rooij, Alejandro Garanto, Rob W J Collin, Frans P M Cremers
Antisense Oligonucleotide-Based Rescue of Complex Intronic Splicing Defects in ABCA4 . Nucleic acid therapeutics (2024)
Zelia Corradi, Rebekkah J Hitti-Malin, Laura A de Rooij, Alejandro Garanto, Rob W J Collin, Frans P M Cremers
Antisense Oligonucleotide-Based Rescue of Complex Intronic Splicing Defects in ABCA4 . Nucleic acid therapeutics 34 (3) (2024)
Nuria Suárez-Herrera, Alejandro Garanto, Rob W J Collin
Understanding and Rescuing the Splicing Defect Caused by the Frequent ABCA4 Variant c.4253+43G>A Underlying Stargardt Disease. Nucleic acid therapeutics 34 (2) (2024)
Nuria Suárez-Herrera, Alejandro Garanto, Rob W J Collin
Understanding and Rescuing the Splicing Defect Caused by the Frequent ABCA4 Variant c.4253+43G>A Underlying Stargardt Disease. Nucleic acid therapeutics 34 (2) (2024)
Irene Vázquez-Domínguez, Alejandro Allo Anido, Lonneke Duijkers, Tamara Hoppenbrouwers, Anita D M Hoogendoorn, Céline Koster, Rob W J Collin, Alejandro Garanto
Efficacy, biodistribution and safety comparison of chemically modified antisense oligonucleotides in the retina. Nucleic acids research (2024)
Haiyan Zhou, Virginia Arechavala-Gomeza, Alejandro Garanto
Experimental Model Systems Used in the Preclinical Development of Nucleic Acid Therapeutics. Nucleic acid therapeutics (2023)
Federica Conte, Angel Ashikov, Rachel Mijdam, Eline G P van de Ven, Monique van Scherpenzeel, Raisa Veizaj, Seyed P Mahalleh-Yousefi, Merel A Post, Karin Huijben, Daan M Panneman, Richard J T Rodenburg, Nicol C Voermans, Alejandro Garanto, Werner J H Koopman, Hans J C T Wessels, Marek J Noga, Dirk J Lefeber
In Vitro Skeletal Muscle Model of PGM1 Deficiency Reveals Altered Energy Homeostasis. International journal of molecular sciences 24 (9) (2023)
Federica Conte, Angel Ashikov, Rachel Mijdam, Eline G P van de Ven, Monique van Scherpenzeel, Raisa Veizaj, Seyed P Mahalleh-Yousefi, Merel A Post, Karin Huijben, Daan M Panneman, Richard J T Rodenburg, Nicol C Voermans, Alejandro Garanto, Werner J H Koopman, Hans J C T Wessels, Marek J Noga, Dirk J Lefeber
In Vitro Skeletal Muscle Model of PGM1 Deficiency Reveals Altered Energy Homeostasis. International journal of molecular sciences 24 (9) (2023)
Imke M E Schuurmans, Bianca Dimitrov, Julian Schröter, Antonia Ribes, Rubén Pérez de la Fuente, Berta Zamora, Clara D M van Karnebeek, Stefan Kölker, Alejandro Garanto
Exploring genotype-phenotype correlations in glutaric aciduria type 1. Journal of inherited metabolic disease (2023)
Federica Conte, Angel Ashikov, Rachel Mijdam, Eline G P van de Ven, Monique van Scherpenzeel, Raisa Veizaj, Seyed P Mahalleh-Yousefi, Merel A Post, Karin Huijben, Daan M Panneman, Richard J T Rodenburg, Nicol C Voermans, Alejandro Garanto, Werner J H Koopman, Hans J C T Wessels, Marek J Noga, Dirk J Lefeber
In Vitro Skeletal Muscle Model of PGM1 Deficiency Reveals Altered Energy Homeostasis. International journal of molecular sciences 24 (9) (2023)
Annemieke M Aartsma-Rus, Alejandro Garanto, Willeke M C van Roon-Mom, Erin M McConnell, Victoria Suslovitch, Winston X Yan, Jonathan K Watts, Timothy W Yu
Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides. Nucleic acid therapeutics 33 (1) (2022)
Annemieke M Aartsma-Rus, Alejandro Garanto, Willeke M C van Roon-Mom, Erin M McConnell, Victoria Suslovitch, Winston X Yan, Jonathan K Watts, Timothy W Yu
Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides. Nucleic acid therapeutics 33 (1) (2022)
Annemieke M Aartsma-Rus, Alejandro Garanto, Willeke M C van Roon-Mom, Erin M McConnell, Victoria Suslovitch, Winston X Yan, Jonathan K Watts, Timothy W Yu
Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides. Nucleic acid therapeutics 33 (1) (2022)
Tomasz Z Tomkiewicz, Sara E Nieuwenhuis, Frans P M Cremers, Alejandro Garanto, Rob W J Collin
Correction of the Splicing Defect Caused by a Recurrent Variant in ABCA4 (c.769-784C>T) That Underlies Stargardt Disease. Cells 11 (24) (2022)
Annemieke M Aartsma-Rus, Alejandro Garanto, Willeke M C van Roon-Mom, Erin M McConnell, Victoria Suslovitch, Winston X Yan, Jonathan K Watts, Timothy W Yu
Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides. Nucleic acid therapeutics (2022)
Tomasz Z Tomkiewicz, Sara E Nieuwenhuis, Frans P M Cremers, Alejandro Garanto, Rob W J Collin
Correction of the Splicing Defect Caused by a Recurrent Variant in ABCA4 (c.769-784C>T) That Underlies Stargardt Disease. Cells 11 (24) (2022)
Annemieke M Aartsma-Rus, Alejandro Garanto, Willeke M C van Roon-Mom, Erin M McConnell, Victoria Suslovitch, Winston X Yan, Jonathan K Watts, Timothy W Yu
Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides. Nucleic acid therapeutics 33 (1) (2022)
Annemieke M Aartsma-Rus, Alejandro Garanto, Willeke M C van Roon-Mom, Erin M McConnell, Victoria Suslovitch, Winston X Yan, Jonathan K Watts, Timothy W Yu
Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides. Nucleic acid therapeutics 33 (1) (2022)
Irene Vázquez-Domínguez, Lonneke Duijkers, Zeinab Fadaie, Eef C W Alaerds, Merel A Post, Edwin M van Oosten, Luke O'Gorman, Michael Kwint, Louet Koolen, Anita D M Hoogendoorn, Hester Y Kroes, Christian Gilissen, Frans P M Cremers, Rob W J Collin, Susanne Roosing, Alejandro Garanto
The Predicted Splicing Variant c.11+5G>A in RPE65 Leads to a Reduction in mRNA Expression in a Cell-Specific Manner. Cells 11 (22) (2022)
Annemieke M Aartsma-Rus, Alejandro Garanto, Willeke M C van Roon-Mom, Erin M McConnell, Victoria Suslovitch, Winston X Yan, Jonathan K Watts, Timothy W Yu
Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides. Nucleic acid therapeutics 33 (1) (2022)
Alejandro Garanto
Delivery of Antisense Oligonucleotides to the Mouse Retina. Methods in molecular biology (Clifton, N.J.) 2434 (2022)
Tomasz Z Tomkiewicz, Sara E Nieuwenhuis, Frans P M Cremers, Alejandro Garanto, Rob W J Collin
Correction of the Splicing Defect Caused by a Recurrent Variant in ABCA4 (c.769-784C>T) That Underlies Stargardt Disease Cells 11 (24) (2022)
Virginia Arechavala-Gomeza, Alejandro Garanto
Antisense RNA Therapeutics: A Brief Overview. Methods in molecular biology (Clifton, N.J.) 2434 (2022)
Tomasz Z Tomkiewicz, Sara E Nieuwenhuis, Frans P M Cremers, Alejandro Garanto, Rob W J Collin
Correction of the Splicing Defect Caused by a Recurrent Variant in ABCA4 (c.769-784C>T) That Underlies Stargardt Disease. Cells 11 (24) (2022)
Tomasz Z Tomkiewicz, Nuria Suárez-Herrera, Frans P M Cremers, Rob W J Collin, Alejandro Garanto
Antisense Oligonucleotide-Based Rescue of Aberrant Splicing Defects Caused by 15 Pathogenic Variants in ABCA4. International journal of molecular sciences 22 (9) (2021)
Suzan M Hammond, Annemieke M Aartsma-Rus, Sandra Alves, Sven Even F Borgos, Ronald A M Buijsen, Rob W J Collin, Giuseppina Covello, Michela Alessandra Denti, Lourdes Ruiz Desviat, Lucía Echevarría, Camilla Foged, Gisela Gaina, Alejandro Garanto, Aurelie T Goyenvalle, Magdalena Guzowska, Irina Kholodnyuk, David R Jones, Sabine Krause, Taavi Lehto, Marisol Montolio, Willeke M C van Roon-Mom, Virginia Arechavala-Gomeza
Delivery of oligonucleotide-based therapeutics: challenges and opportunities. EMBO molecular medicine 13 (4) (2021)
Mubeen Khan, Stéphanie S Cornelis, Riccardo Sangermano, Iris J M Post, Amber Janssen Groesbeek, Jan Amsu, Christian Gilissen, Alejandro Garanto, Rob W J Collin, Frans P M Cremers
In or Out? New Insights on Exon Recognition through Splice-Site Interdependency. International journal of molecular sciences 21 (7) (2020)

Alejandro Garanto.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alejandro Garanto